MedPath

Multicenter study of transcranial doppler in acute hepatic failure patients to predict encephalopathy onset

Not Applicable
Conditions
Health Condition 1: K720- Acute and subacute hepatic failureHealth Condition 2: T604- Toxic effect of rodenticides
Registration Number
CTRI/2021/02/031428
Lead Sponsor
Amrita institute of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having acute liver failure

Exclusion Criteria

Age less than 18

Hemodynamics instability

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the sensitivity of resistive index to predict onset of severe encephalopathy ( grade 3 or intubation ) by 48 hours in.adult acute liver failure patientsTimepoint: Daily , for 7 days
Secondary Outcome Measures
NameTimeMethod
To evaluate the sensitivity of Resistive Index (RI) to predict onset of severe encephalopathy (Grade 3 or above, or intubation) by 72 hours in adult Acute Liver Failure (ALF) patientsTimepoint: 72 hours;. To evaluate the sensitivity of Pulsatility Index (PI) to predict onset of severe encephalopathy (Grade 3 or above, or intubation) by 72 hours in adult Acute Liver Failure (ALF) patients.Timepoint: 72 hours;To evaluate other indices like Pulsatility Index (PI) to predict onset of severe encephalopathy (Grade 3 or above, or intubation) by 48 hours in adult Acute Liver Failure (ALF) patients. <br/ ><br>Timepoint: 48 hours;To evaluate the correlation of arterial ammonia with degree of encephalopathyTimepoint: 72 hours;To evaluate the correlation of the RI, PI and arterial ammonia to grade of encephalopathy as the patient recovers, in those who recover either spontaneously or after liver transplantationTimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath